Think.Health

Robeaute is a research and development agency that develops neurosurgical microrobots that can adapt to different types of medical evidence.

Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, founded in 2016. The company specializes in developing rapid tests that assess the immune system to address significant clinical and public health challenges. Its primary focus is on creating diagnostics for acute bacterial and viral infections, as well as sepsis, utilizing patent-pending biomarkers exclusively licensed from Stanford University. Inflammatix employs proprietary machine-learning algorithms to analyze immune responses, producing clinically actionable results that support healthcare providers, particularly in emergency medicine, in making informed diagnostic decisions. Additionally, the company is building a diagnostics pipeline that includes tests for tropical infections, autoimmune diseases, transplant rejection, and various other conditions.

Sphingotec GmbH is a biotechnology company based in Brandenburg, Germany, founded in 2002. The company specializes in the development of innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions, including acute heart failure, acute kidney injury, and circulatory shock. Sphingotec focuses on creating in vitro diagnostic solutions that utilize proprietary blood-based protein biomarkers. In addition to its diagnostic offerings, the company develops microtiter plates, which are essential tools in analytical research and diagnostic testing laboratories. By addressing diagnostically underserved critical care conditions, Sphingotec aims to improve patient outcomes through enhanced diagnostic capabilities.

Myo is a communication platform specifically developed for the elderly care market. It facilitates connections between elderly individuals and their families, enhancing communication through familiar messaging features. The platform allows caregivers to share various forms of content, including photos, videos, texts, and voice messages, ensuring that interactions are professional, secure, and direct. Myo aims to improve the overall care experience by fostering meaningful connections among caregivers, elderly individuals, and their relatives. The company is also focused on expanding its team with talented individuals dedicated to enhancing care solutions.

Selfapy GmbH is a Berlin-based company that specializes in developing online therapy programs aimed at individuals affected by depression and other psychological disorders. Since its founding in 2016, Selfapy has offered a range of programs addressing issues such as anxiety, eating disorders, stress, and chronic panic. The company provides users with a guided self-help experience, featuring exercises, videos, and texts delivered over a three-month period via phone or SMS. With a focus on recognizing negative thought patterns and promoting new behaviors, Selfapy's anonymous and flexible therapy solutions are designed to support users in managing their mental health effectively.

Navignostics is focused on improving cancer treatment by using spatial single-cell proteomics to characterize tumors. The company aims to identify the most effective therapies for individual patients, thereby enhancing personalized diagnostics and reducing patient suffering. In addition to tailoring treatments, Navignostics accelerates cancer drug development by offering critical insights into drug mechanisms and tumor characteristics, which are essential for companion diagnostic development. This approach not only enables clinicians to make informed treatment recommendations but also increases the availability of effective drugs for cancer patients. By leveraging its advanced technology and data analytics, Navignostics provides valuable services to pharmaceutical and biotech partners, ultimately contributing to better outcomes for those affected by cancer.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Anvajo, originally founded at TU Dresden, specializes in point-of-care technology for diagnostic testing of liquids. The company has developed a portable diagnostic device that integrates spectroscopy and microscopy, making it versatile for applications in human and veterinary medicine, as well as food, feed, and environmental analysis. This innovative platform allows healthcare professionals to diagnose symptoms and diseases more easily. Anvajo has experienced continuous growth and expanded its operations, moving into a new headquarters in Dresden in January 2020, where it consolidates development, production, and support functions under one roof.

Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, founded in 2016. The company specializes in developing rapid tests that assess the immune system to address significant clinical and public health challenges. Its primary focus is on creating diagnostics for acute bacterial and viral infections, as well as sepsis, utilizing patent-pending biomarkers exclusively licensed from Stanford University. Inflammatix employs proprietary machine-learning algorithms to analyze immune responses, producing clinically actionable results that support healthcare providers, particularly in emergency medicine, in making informed diagnostic decisions. Additionally, the company is building a diagnostics pipeline that includes tests for tropical infections, autoimmune diseases, transplant rejection, and various other conditions.

Myo is a communication platform specifically developed for the elderly care market. It facilitates connections between elderly individuals and their families, enhancing communication through familiar messaging features. The platform allows caregivers to share various forms of content, including photos, videos, texts, and voice messages, ensuring that interactions are professional, secure, and direct. Myo aims to improve the overall care experience by fostering meaningful connections among caregivers, elderly individuals, and their relatives. The company is also focused on expanding its team with talented individuals dedicated to enhancing care solutions.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

SpinDiag GmbH is a medical technology company based in Freiburg, Germany, focused on developing automated point-of-care systems for the rapid and reliable detection of infectious diseases. Founded in 2016, the company has created a centrifugal-microfluidic test system that allows healthcare providers to screen for the 25 most common antibiotic resistances directly from patient samples upon hospital admission. This innovative system helps prevent the spread of drug-resistant bacteria by enabling the immediate isolation of infected patients. SpinDiag's first product is an automated SARS-CoV-2 test that provides laboratory-grade PCR results directly from standard patient swab samples, streamlining the workflow for nurses and integrating seamlessly into clinical practice. The fully automated system eliminates the need for manual pipetting, thereby minimizing the risk of infection and enhancing the efficiency of pathogen detection in hospital settings.

Endodont GmbH, founded in 2017 and based in Berlin, Germany, specializes in developing innovative products and processes for the dental industry, particularly focusing on root canal treatments. The company aims to enhance root canal fillings with technologies that ensure safe and effective closure of the root canal. Its offerings include advanced solutions such as anti-leakage technology, inflammation-proof techniques, and denser filling materials, all designed to improve treatment stability and reduce the duration of procedures. By prioritizing patient safety and efficacy, Endodont seeks to transform dental care practices related to root canal therapy.

Selfapy GmbH is a Berlin-based company that specializes in developing online therapy programs aimed at individuals affected by depression and other psychological disorders. Since its founding in 2016, Selfapy has offered a range of programs addressing issues such as anxiety, eating disorders, stress, and chronic panic. The company provides users with a guided self-help experience, featuring exercises, videos, and texts delivered over a three-month period via phone or SMS. With a focus on recognizing negative thought patterns and promoting new behaviors, Selfapy's anonymous and flexible therapy solutions are designed to support users in managing their mental health effectively.

Caspar Health is a provider of digital rehabilitation services that facilitates recovery for individuals following illness or accidents. The company offers an online virtual rehabilitation platform that enables healthcare professionals to deliver tailored, tele-rehabilitation care. This platform includes preconfigured therapy plans that consist of movement exercises, educational seminars, lectures, and relaxation modules, allowing for effective patient care regardless of time and location. Caspar Health is recognized for its contributions to tele-rehabilitation aftercare, particularly through its collaboration with the German Pension Fund. The aim of Caspar Health is to enhance accessibility to rehabilitation services and support individuals in regaining their independence.

Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, founded in 2016. The company specializes in developing rapid tests that assess the immune system to address significant clinical and public health challenges. Its primary focus is on creating diagnostics for acute bacterial and viral infections, as well as sepsis, utilizing patent-pending biomarkers exclusively licensed from Stanford University. Inflammatix employs proprietary machine-learning algorithms to analyze immune responses, producing clinically actionable results that support healthcare providers, particularly in emergency medicine, in making informed diagnostic decisions. Additionally, the company is building a diagnostics pipeline that includes tests for tropical infections, autoimmune diseases, transplant rejection, and various other conditions.

M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

First Light Diagnostics Inc. specializes in the development of automated medical diagnostic products aimed at detecting microbes responsible for healthcare-associated infections. The company is known for its benchtop MultiPath analyzer, which identifies both resistant and sensitive strains of Staphylococcus aureus, as well as various toxins and viruses, making it suitable for hospital clinical microbiology laboratories. Its products address multiple applications, including the screening of blood, surgical, skin, and gastrointestinal infections. By offering rapid and cost-effective testing solutions, First Light Diagnostics meets the increasing demand for accurate diagnostics, which is essential for reducing hospital infection rates. The company's proprietary MultiPath detection technology combines the efficiency of advanced laboratory tests with affordability and ease of use. Founded in 2006 and based in Chelmsford, Massachusetts, First Light Diagnostics was previously known as First Light Biosciences until its name change in January 2019.

PreOmics GmbH, founded in 2016 and based in Planegg, Germany, specializes in mass spectrometry (MS)-based proteomics. The company develops innovative tools, including the iST Kit, designed for efficient sample preparation and peptide pre-fractionation, which allows researchers to process peptide mixtures in just one hour. PreOmics focuses on providing solutions for the identification of protein interaction partners, large-scale protein discovery, and quantification of proteins, as well as the analysis of post-translational modifications. As a spin-off from the Max-Planck Institute of Biochemistry, the company aims to enhance protein analysis for researchers worldwide by offering high-quality technologies that streamline and improve research outcomes.

Myo is a communication platform specifically developed for the elderly care market. It facilitates connections between elderly individuals and their families, enhancing communication through familiar messaging features. The platform allows caregivers to share various forms of content, including photos, videos, texts, and voice messages, ensuring that interactions are professional, secure, and direct. Myo aims to improve the overall care experience by fostering meaningful connections among caregivers, elderly individuals, and their relatives. The company is also focused on expanding its team with talented individuals dedicated to enhancing care solutions.

Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, founded in 2016. The company specializes in developing rapid tests that assess the immune system to address significant clinical and public health challenges. Its primary focus is on creating diagnostics for acute bacterial and viral infections, as well as sepsis, utilizing patent-pending biomarkers exclusively licensed from Stanford University. Inflammatix employs proprietary machine-learning algorithms to analyze immune responses, producing clinically actionable results that support healthcare providers, particularly in emergency medicine, in making informed diagnostic decisions. Additionally, the company is building a diagnostics pipeline that includes tests for tropical infections, autoimmune diseases, transplant rejection, and various other conditions.

Selfapy GmbH is a Berlin-based company that specializes in developing online therapy programs aimed at individuals affected by depression and other psychological disorders. Since its founding in 2016, Selfapy has offered a range of programs addressing issues such as anxiety, eating disorders, stress, and chronic panic. The company provides users with a guided self-help experience, featuring exercises, videos, and texts delivered over a three-month period via phone or SMS. With a focus on recognizing negative thought patterns and promoting new behaviors, Selfapy's anonymous and flexible therapy solutions are designed to support users in managing their mental health effectively.

M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

Omnicare Pharma is a pharmaceutical wholesaler that specializes in distributing finished medicinal products to compounding pharmacies, focusing primarily on the production of patient-specific cancer medications. The company aims to support outpatient oncology care by providing a range of pharmaceutical products and related services through its nationwide network of compounding pharmacies. This approach enables patients to access specialized medicines and services more efficiently and conveniently, improving their treatment experience in local settings.

Smarterials Technology GmbH, founded in 2016 and headquartered in Berlin, Germany, specializes in the design and development of advanced surgical gloves. These gloves feature a dual-barrier system and perforation indicators that actively alert healthcare professionals to potential infection risks. By providing enhanced protection, Smarterials' products aim to replace traditional double-gloving methods, ultimately reducing the risk of injury and infection for medical staff. The innovative design not only helps prevent contamination from potentially infectious materials but also improves operational efficiency in hospitals and care facilities, allowing for better resource management and cost savings.

Caspar Health is a provider of digital rehabilitation services that facilitates recovery for individuals following illness or accidents. The company offers an online virtual rehabilitation platform that enables healthcare professionals to deliver tailored, tele-rehabilitation care. This platform includes preconfigured therapy plans that consist of movement exercises, educational seminars, lectures, and relaxation modules, allowing for effective patient care regardless of time and location. Caspar Health is recognized for its contributions to tele-rehabilitation aftercare, particularly through its collaboration with the German Pension Fund. The aim of Caspar Health is to enhance accessibility to rehabilitation services and support individuals in regaining their independence.

Endodont GmbH, founded in 2017 and based in Berlin, Germany, specializes in developing innovative products and processes for the dental industry, particularly focusing on root canal treatments. The company aims to enhance root canal fillings with technologies that ensure safe and effective closure of the root canal. Its offerings include advanced solutions such as anti-leakage technology, inflammation-proof techniques, and denser filling materials, all designed to improve treatment stability and reduce the duration of procedures. By prioritizing patient safety and efficacy, Endodont seeks to transform dental care practices related to root canal therapy.

M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

HelloCare is an online care and support marketplace that helps users find caregivers and domestic helpers in their cities. People can select the day, time, and the scope of services; receive a personal message with information on the representative or domestic helper assigned for them; visit the online profile of the candidate and see the reviews of other customers; and make payments via online tools to book the service. HelloCare enables independent caregivers and domestic workers to register as partners, access customer orders, and work without a direct boss.

Caspar Health is a provider of digital rehabilitation services that facilitates recovery for individuals following illness or accidents. The company offers an online virtual rehabilitation platform that enables healthcare professionals to deliver tailored, tele-rehabilitation care. This platform includes preconfigured therapy plans that consist of movement exercises, educational seminars, lectures, and relaxation modules, allowing for effective patient care regardless of time and location. Caspar Health is recognized for its contributions to tele-rehabilitation aftercare, particularly through its collaboration with the German Pension Fund. The aim of Caspar Health is to enhance accessibility to rehabilitation services and support individuals in regaining their independence.

HyHelp AG is a company based in Frankfurt am Main, Germany, that specializes in developing mobile devices and software tools for hygiene management in healthcare settings. Its innovative device is designed to assist healthcare professionals, including doctors and nurses, in enhancing hand hygiene practices, thereby reducing the incidence of nosocomial infections and improving overall patient safety. By enabling hospitals and other healthcare institutions to effectively track and monitor hand hygiene events, HyHelp plays a crucial role in promoting better hygiene standards within the medical community.

HyHelp AG is a company based in Frankfurt am Main, Germany, that specializes in developing mobile devices and software tools for hygiene management in healthcare settings. Its innovative device is designed to assist healthcare professionals, including doctors and nurses, in enhancing hand hygiene practices, thereby reducing the incidence of nosocomial infections and improving overall patient safety. By enabling hospitals and other healthcare institutions to effectively track and monitor hand hygiene events, HyHelp plays a crucial role in promoting better hygiene standards within the medical community.

Pedanios GmbH, founded in 2015 and headquartered in Berlin, Germany, specializes in the distribution of pharmaceutical products, particularly licensed narcotic drugs. The company focuses on providing high-quality medicines by collaborating with a network of producers and implementing rigorous quality and safety measures. Pedanios operates as a subsidiary of Aurora Cannabis Inc. and has established an exclusive supply agreement with Cronos Group, which designates Cronos as the exclusive North American supplier of cannabis products for distribution within the European Union. This strategic partnership enhances Pedanios' ability to meet the growing demand for cannabis-based pharmaceuticals in Europe.

Urban Sports Club offers a flexible sports flatrate. The mission is to help people lead a more healthy and active lifestyle. Club members can choose from more than 50 types of sports – ranging from classic gym workout, swimming, yoga, or bouldering, to team sports, wellness and lots more – and more than 10.000 partner venues in Germany, France, Italy, Spain, Portugal and Belgium. Variety, flexible conditions as well as team sports and wellness are offered both for private customers and companies. Urban Sports GmbH was founded in 2012 by Moritz Kreppel and Benjamin Roth in Berlin, Germany. After two years of bootstrapping, the company secured an early-stage financing in 2015 and went on to acquire four of its German competitors, starting with Somuchmore in December, 2016. In January 2018, FITrate came on board, with INTERFIT following in December of the same year. OneFit joined the Urban Sports Club family in August of 2019.